Pro-inflammatory activity of phospholipase A2 in CAPD patients with and without peritonitis
Jassal, S.V.; Morton, A.R.; Vadas, P.; Pruzanski, W.; Stefanski, E.; Pierratos, A.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 17(2): 197-199
1997
ISSN/ISBN: 0896-8608 PMID: 9159844 Document Number: 477551
Document emailed within 1 workday
Related Documents
Zemel, D.; Betjes, M.G.; Dinkla, C.; Struijk, D.G.; Krediet, R.T. 1995: Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 15(2): 134-141Chou, C.-Y.; Kao, M.-T.; Kuo, H.-L.; Liu, J.S.; Liu, Y.-L.; Huang, C.-C. 2006: Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(5): 607-608
Vlasov, A.P.; Trofimov, V.A.; Tarasova, T.V.; Sudakova, G.Iu.; Poderov, V.N.; Saushev, I.V.; Rubtsov, O.Iu.; Dubovskaia, T.N.; Aksenova, S.V. 2000: Changes in phospholipase A2 activity and lipid peroxidation in endotoxicosis during experimental peritonitis Biulleten' Eksperimental'noi Biologii i Meditsiny 129(1): 31-33
Anding, K.; Krumme, B.; Pelz, K.; Böhler, J.; Schollmeyer, P. 1996: Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis International Journal of Clinical Pharmacology and Therapeutics 34(11): 465-469
Vargemezis, V.; Natscheh, T.; Belechri, A.M.; Tsobanelis, T.; Eustratiadis, G.; Papadimitriou, M. 1984: Pseudomonas peritonitis in patients of CAPD Life Support Systems: the Journal of the European Society for Artificial Organs 2(4): 294-296
Williams, P.F.; Foggensteiner, L. 2002: Sterile/allergic peritonitis with icodextrin in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 22(1): 89-90
Lye, W.C.; Lee, E.J.; Ang, K.K. 1991: Acinetobacter peritonitis in patients on CAPD: characteristics and outcome Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 7: 176-179
Sirivongs, D.; Pongskul, C.; Keobounma, T.; Chunlertrith, D.; Sritaso, K.; Johns, J. 2006: Risk factors of first peritonitis episode in Thai CAPD patients Journal of the Medical Association of Thailand 89(Suppl 2): S138-S145
Tambawala, A.Q.; Hamid, S.; Khan, I.; Ali, A. 2011: Continuous ambulatory peritoneal dialysis (CAPD) associated peritonitis in a child: a rare case of peritonitis caused by sphingomonous paucimobilis JPMA. Journal of the Pakistan Medical Association 61(2): 178-180
Bunnag, S.; Thanakitcharu, P.; Krairittichai, U.; Jirajan, B.; Meenune, W.; Kanjanapanth, C. 2011: Risk factors of infectious peritonitis of CAPD patients in Rajavithi Hospital Journal of the Medical Association of Thailand 94(Suppl 4): S37-S43
Bozkurt, F.; Keller, E.; Schollmeyer, P.; Kappe, R.; Müller, J. 1988: Candida peritonitis in 2 patients on continuous ambulatory peritoneal dialysis (CAPD) Mycoses Suppl 1: 69-74
Carozzi, S.; Nasini, M.G.; Schelotto, C.; Caviglia, P.M.; Canepa, M.; Zanin, T.; Cantaluppi, A.; Salit, M. 1990: Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 6: 106-109
Yip, T.; Tse, K.-C.; Lam, M.-F.; Tang, S.; Li, F.-K.; Choy, B.-Y.; Lui, S.-L.; Chan, T.-M.; Lai, K.-N.; Lo, W.-K. 2006: Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(2): 191-197
Lin, C.Y.; Chen, W.P.; Fu, L.W.; Yang, L.Y.; Huang, T.P. 1997: Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 13: 64-71
Liawnoraset, W. 2011: Prevalence and factors affecting peritonitis in CAPD patients in Maharat Nakhon Ratchasima Hospital under universal coverage scheme during 2008-2010: a three-year experience Journal of the Medical Association of Thailand 94 Suppl. 4: S19-S24
Takakuwa, T.; Endo, S.; Inada, K.; Kasai, T.; Yamada, Y.; Ogawa, M. 1997: Assessment of inflammatory cytokines, nitrate/nitrite, type Ii phospholipase A2, and soluble adhesion molecules in systemic inflammatory response syndrome Research Communications in Molecular Pathology and Pharmacology 98(1): 43-52
Kawada, Y.; Kuriyama, M. 1992: CAPD related peritonitis Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 757-762
Janknegt, R. 1991: CAPD peritonitis and fluoroquinolones: a review Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 11(1): 48; 53-58
Miller, G.V.; Bhandari, S.; Brownjohn, A.M.; Turney, J.H.; Benson, E.A. 1998: 'Surgical' peritonitis in the CAPD patient Annals of the Royal College of Surgeons of England 80(1): 36-39
Prakash, K.C. 1996: Giardial peritonitis complicating CAPD Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 16(3): 327